Bank of America’s Decoy Therapeutics DCOY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-3
| Closed | -$23 | – | 6733 |
|
|
2025
Q4 | $23 | Buy |
+3
| New | +$78 | ﹤0.01% | 7099 |
|
|
2025
Q3 | – | Hold |
0
| – | – | – | 8192 |
|
|
2025
Q2 | – | Hold |
0
| – | – | – | 8264 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 8219 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 8023 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 7930 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 8046 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 7558 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 7777 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 7572 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 8706 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 8597 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 8362 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 8053 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 7144 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 7103 |
|
|
2019
Q4 | – | Hold |
0
| – | -$10K | – | 7366 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6725 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 7391 |
|
|
2018
Q4 | – | Hold |
0
| – | -$3K | – | 7353 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6962 |
|
|
2018
Q2 | – | Hold |
0
| – | -$1K | – | 7297 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 6980 |
|
|
2017
Q3 | – | Hold |
0
| – | -$13K | – | 7245 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6357 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6464 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 6212 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6504 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 5210 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 5099 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 5585 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 6714 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 6973 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 6840 |
|
Other funds holding DCOY
Bank of America's DCOY Position: Q1 2026 in Review
Bank of America sold out of Decoy Therapeutics (DCOY) in Q1 2026, closing a stake of 3 shares — an estimated $23 sold.
Bank of America first reported a position in DCOY in Q4 2025 and held it in 1 quarter. The position peaked at $23 in Q4 2025. 4 funds tracked by Wall St. Rank hold DCOY as of Q1 2026.
- Bank of America reported no remaining Decoy Therapeutics position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 3 Decoy Therapeutics shares in Q1 2026, an estimated $23.
- Bank of America first reported a position in Decoy Therapeutics in Q4 2025 and held it in 1 quarter.
- Bank of America's Decoy Therapeutics position peaked at $23 in Q4 2025.
- 4 funds tracked by Wall St. Rank held Decoy Therapeutics as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.